Journal Information
Vol. 31. Issue 3.
Pages 101-108 (March 1995)
Vol. 31. Issue 3.
Pages 101-108 (March 1995)
Full text access
Naturaleza del humo del tabaco. Farmacología de la nicotina
Visits
16457
A. Pérez Trullén*
Profesor Asociado de la Facultad de Medicina de la Universidad de Zaragoza. Servicio de Neumología. Hospital Universitario Lozano Blesa. Zaragoza
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D. Hoffmann, E.L. Wynder.
Chemical constituents and bioactivity of tobacco smoke.
Tobacco: a major international health hazard,
[2.]
B.J. Ingebrethsen.
Aerosol studies of cigarette smoke.
Recent Ad Tobacco Sci, 12 (1986), pp. 142
[3.]
US., Department of Health, Human Services, Public Health Service.
The Health Consequences of smoking: Cancer.
A Report of the Surgeon General. DHHS (CDC) Publication N. ° 82-50179, US Government Printing Office, (1982),
[4.]
N.L. Benowitz.
Pharmacokinetic considerations m understanding nicotine dependence. The biology of nicotine dependence.
Wiley Chichester (Ciba Foundation Symposium 152), (1990), pp. 186-209
[5.]
H. Schievelbein.
Nicotina. En: Enciclopedia de Salud y Seguridad en el Trabajo.
L Parmeggiani, eds. Centro de Publicaciones del Ministerio de Trabajo y Seguridad Social, (1989), pp. 1. 625-1. 626
[6.]
J. Le Houezec, N.L. Benowitz.
Basic clinical psychopharmacology of nicotine.
Clinics in Chest Medicine, pp. 681-699
[7.]
N.L. Benowitz.
Pharmacokinetics and pharmacodynamics of nicotine.
pp. 3-18
[8.]
W.W. Mapleson.
Circulation-time models of the uptake of inhaled anesthesics and data for quantifying them.
Br J Anaesth, 45 (1973), pp. 319-334
[9.]
M. Curvall, C.R. Enzell.
Monitoring absorption by means of determination of nicotine and cotinine.
Arch Toxicol, 9 (1986), pp. 88-102
[10.]
C. Izard.
Neuropsychologie du tabac.
Masson et Cie, (1976),
[11.]
M.J. Rand.
Neuropharmacological effeets of nicotine in relation to cholinergic mechanisms.
Progress in Brain Research: Nicotinic receptors in the CNS, their role in synaptic transmission. Amsterdam:, pp. 3-11
[12.]
N.L. Benowitz, H. Porchet, J. Peyton.
Pharmacokinetics metabolism and pharmacodynamics of nicotine.
pp. 112-157
[13.]
N.L. Benowitz.
Tabaquismo de cigarrillos y adicción a la nicotina.
Tabaquismo de cigarrillos: Guía clínica para la valoración y el tratamiento. Clínicas Médicas de Norteamérica, pp. 409-433
[14.]
M.A. Russell.
Subjective and behavioural effects of nicotine in humans: some sources of individual variation.
pp. 289-301
[15.]
O.F. Pomerleau.
Nicotine and the central nervous System: Biobehavioral effeets of cigarette smoking.
Am J Med, 93 (1992), pp. 2-7
[16.]
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed.
(3., a, ed., revisada), American Psychiatric Association, (1978),
[17.]
A.H. Beckett.
A possible relation between pKa, and lipid solubility and the amounts excreted in uriñe of some tobacco alkaloids given to man.
J Pharm Pharmacol, 24 (1972), pp. 115-120
[18.]
L. Miller.
Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.
Clin Pharmacokinet, 17 (1989), pp. 90-108
[19.]
US., Department of Health, Human Services, Public Health Service.
The Health Consequences of Smoking: Nicotine Addiction.
A Report of the Surgeon General. DHHS (CDC) Publication N. ° 88-8406, US Government Printing Office, (1988),
[20.]
W.A. Hunt, L.W. Barnett.
Relapse rates in addiction programs.
J Clin Psychol, 27 (1971), pp. 455
[21.]
C. Cohen, W.B. Pickworth, J.E. Henningfield.
Cigarette smoking and addiction.
Smoking cessation. Clinics in Chest Medicine, pp. 701-710
[22.]
E.B. Fisher, D. Haire-Joshu, G.D. Morgan, et al.
State of the Art: Smoking and Smoking cessation.
Am Rev Respir Dis, 142 (1990), pp. 702-720
[23.]
K.O. Fargerstrom.
Tobacco smoking, nicotine dependence and smoking cessation.
Acta Univ Upsaliensis, (1981),
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica